This proposal describes a 3 year program to investigate the relations between childhood dysregulation and adult substance abuse, psychopathology, and metabolic syndrome. In this COBRE Project the junior principal investigator, an M.D., Ph.D. with training in child and adolescent psychiatry will work with primary mentor James Hudziak, MD, senior mentors Hugh Garavan, MD and Phil Ades, MD to investigate the metabolic, epigenetic, executive function/decision-making, and psychophysiological mechanisms of a child behavioral syndrome termed """"""""dysregulation."""""""" The study proposes that dysregulation is a common prodrome for a variety of negative adult outcomes (substance abuse, persistent psychopathology, and the cluster of non-psychiatric disorders referred to as """"""""Metabolic Syndrome"""""""" (MS) - diabetes, dyslipedemia, hypertension, and obesity. We propose a model consisting of environmental impact (e.g., low socioeconomic status, chronic adversity) on a genetic predisposition (e.g., family history of self-regulatory problems) affecting the systems involved in self-regulation. The dysregulatory effects in turn affect gluocorticoid and autonomic nervous system (e.g., heart rate variability) responses. We will test this model through the use of a family study approach. In order to do this work, we propose adding measurement of metabolic, epigenetic, executive function/decision-making, and psychophysiological data to parents of children in an ongoing family study of children with dysregulation (NIMH K08MH082116). Through the course of the 3 year study, we will determine the rates of substance use disorders, psychopathology, and metabolic syndrome in the families of children with dysregulation. We will determine the rates of delay discounting (a measure of impulsivity) and the levels of heart rate variability (a measure of autonomic stability) in these children and their families. Using two complementary methods, we will determine the epigenetic profiles in dysregulated children and their family members in two gene promoters known to be associated withs stress reactivity (NR3C1 and FKBP5).
Determining the mechanisms of how behavioral symptoms can lead to later adult outcomes has the potential to significantly reduce morbidity and mortality. Here, we propose to examine a pattern of poor selfregulation in childhood and predict associations with obesity, hypertension, diabetes, substance abuse, and psychiatric disorders in their families. We predict a mechanism involving genes involved in stress reactivity.
|Sigmon, Stacey C; Schwartz, Robert P; Higgins, Stephen T (2017) Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence. N Engl J Med 376:1000-1001|
|Higgins, Stephen T; Reed, Derek D; Redner, Ryan et al. (2017) Simulating demand for cigarettes among pregnant women: A Low-Risk method for studying vulnerable populations. J Exp Anal Behav 107:176-190|
|McMahon, Sean R; Ades, Philip A; Thompson, Paul D (2017) The role of cardiac rehabilitation in patients with heart disease. Trends Cardiovasc Med 27:420-425|
|Villanti, Andrea C; Johnson, Amanda L; Ilakkuvan, Vinu et al. (2017) Social Media Use and Access to Digital Technology in US Young Adults in 2016. J Med Internet Res 19:e196|
|Higgins, Stephen T; Heil, Sarah H; Sigmon, Stacey C et al. (2017) Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology (Berl) 234:89-98|
|Gaalema, Diann E; Savage, Patrick D; Rengo, Jason L et al. (2017) Patient Characteristics Predictive of Cardiac Rehabilitation Adherence. J Cardiopulm Rehabil Prev 37:103-110|
|Phillips, Julie K; Higgins, Stephen T (2017) Applying behavior change techniques to weight management during pregnancy: Impact on perinatal outcomes. Prev Med 104:133-136|
|Gaalema, Diann E; Elliott, Rebecca J; Morford, Zachary H et al. (2017) Effect of Socioeconomic Status on Propensity to Change Risk Behaviors Following Myocardial Infarction: Implications for Healthy Lifestyle Medicine. Prog Cardiovasc Dis 60:159-168|
|Matusiewicz, Alexis K; Melbostad, Heidi S; Heil, Sarah H (2017) Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder. Contraception 96:365-369|
|Brooklyn, John R; Sigmon, Stacey C (2017) Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact. J Addict Med 11:286-292|
Showing the most recent 10 out of 105 publications